Skip to main content
. 2020 Sep 8;22(2):e13137. doi: 10.1111/obr.13137

TABLE 3.

Network meta‐analysis matrix of results

Outcome

Comparison of treatments: Mean difference (95% confidence intervals)

Effect of intervention in each row compared with intervention in each column

Weight (kg)
CON AE‐V AE‐M R‐HI R‐LM COM‐HI COM‐LM
CON −0.65 (−1.08, −0.17) −0.75 (−1.24, −0.26) −0.63 (−1.55, 0.24) −0.05 (−0.69, 0.59) −1.01 (−2.71, −0.40) −0.83 (−2.03, −0.36)
AE‐V −0.12 (−0.71, 0.47) −0.03 (−1.01, 0.96) 0.58 (−0.16, 1.32) −0.38 (−1.14, 0.38)
AE‐M 0.70 (−0.05, 1.46) −0.08 (−1.36, 1.19)
R‐HI −0.10 (1.00, 0.81) −0.18 (−1.67, 1.31)
R‐LM −0.61 (−1.69, 0.47) −0.96 (−1.79, −0.14)
COM‐HI 0.21 (−1.03, 1.44) 0.79 (−0.50, 2.07) −0.18 (−1.52, 1.17)
COM‐LM 0.26 (−0.47, 0.99) 0.35 (−0.68, 1.39)
Body mass index (BMI)
CON AE‐V AE‐M R‐HI R‐LM COM‐HI COM‐LM
CON −0.94 (−1.72, −0.15) −1.76 (−2.58, −0.95) −0.93 (−2.48, 0.61) −0.31 (−1.47, 0.85) −2.79 (−5.95, −0.36) −1.56 (−2.71, −0.41)
AE‐V −0.83 (−1.79, 0.14) 0.63 (−0.71, 1.97) −1.86 (−5.11, 1.40) −0.63 (−1.95, 0.70)
AE‐M 0.83 (−0.73, 2.39) −1.03 (−4.29, 2.23) 0.20 (− 1.06, 1.46)
R‐HI −0.01 (−1.69, 1.68) −1.86 (−5.37, 1.65) −0.63 (−2.43, 1.16)
R‐LM −1.45 (−2.77,‐0.14) −0.62 (−1.26, 2.51)
COM‐HI 2.48 (0.88, −5.84)
COM‐LM 1.25 (−0.19, 2.07) −1.23 (−4.59, 2.13)
Waist circumference (cm)
CON AE‐V AE‐M R‐HI R‐LM COM‐HI COM‐LM
CON −2.03 (−3.55, −0.52) −2.31 (−3.61, −1.02) −1.62 (−3.39, 0.15) −1.43 (−3.75, 0.89) −2.76 (−4.52, −1.00)
AE‐V −0.28 (−1.98, 1.42) 0.60 (−2.03, 3.23) −0.73 (−2.90, 1.44)
AE‐M 0.69 (−1.16, 2.55) −0.45 (−2.43, 1.53)
R‐HI −0.41 (−2.64, 1.81) −1.14 (−3.47, 1.19)
R‐LM −0.88 (−3.49, 1.72) −0.19 (−3.08, 2.69) −1.33 (−4.07, 1.41)
COM‐HI ‐‐
COM‐LM
Percentage body fat (%)
CON AE‐V AE‐M R‐HI R‐LM COM‐HI COM‐LM
CON −1.27 (−2.59, 0.05) −1.70 (−3.16, −0.25) −1.81 (−3.97, 0.35) −1.47 (−3.60, 0.65) −2.82 (−5.50, −0.14) −2.15 (−4.06, −0.25)
AE‐V −0.43 (−2.24, 1.37) −0.20 (−2.57, 2.16) −0.89 (−3.15, 1.38)
AE‐M −0.11 (−2.41, 2.19) 0.23 (−2.19, 2.65) −1.12 (−4.12, 1.88)
R‐HI 0.54 (−1.94, 3.30) −1.01 (−4.43, 2.41)
R‐LM −0.34 (−3.30, 2.63) −1.35 (−4.46, 1.77) −0.68 (−3.34, 1.97)
COM‐HI 1.55 (−1.29, 4.39)
COM‐LM 0.45 (−1.70, 2.61) 0.35 (−2.30, 2.99) −0.67 (−3.91, 2.58)
Cardiorespiratory fitness (VO2max, L min−1)
CON AE‐V AE‐M R‐HI R‐LM COM‐HI COM‐LM
CON 1.29 (−4.66, 2.08) 1.39 (−2.77, 3.37) 1.11 (−8.43, 4.93) 0.14 (−5.55, 5.69) 1.76 (−5.35, 8.87) 0.24 (−0.11.4, 2.93)
AE‐V 1.59 (−2.44, 5.62) −1.43 (−4.99, 7.84) 3.05 (−4.73, 10.83)
AE‐M −2.10 (−8.97, 4.96) −4.54 (−12.2, 3.14)
R‐HI 0.42 (−6.37, 7.20) 3.46 (−6.19, 13.12)
R‐LM 0.26 (−5.53, 5.92) 1.84 (−10.72, 6.74) 1.38 (−13.56, 4.70)
COM‐HI −1.46 (−8.84, 5.94) −1.62 (−9.86, 6.62)
COM‐LM 2.95 (−4.55, 10.74) −0.54 (−6.17, 5.25) 6.00 (−16.07, 4.07)

Note: Direct comparisons are reported above the grey line whereas indirect comparisons are reported in italics below the grey line. Weight, BMI, WC and %BF: clinically desirable outcome is a decrease (−). Cardiorespiratory fitness: clinically desirable outcome is an increase (+).

Abbreviations: AE‐M, aerobic moderate intensity; AE‐V, aerobic vigorous intensity; COM‐HI, combination of high‐intensity aerobic and high‐load resistance exercise; COM‐LM, combination of low‐moderate intensity aerobic and low‐moderate load resistance exercise; R‐HI, resistance high load; R‐LM, resistance low‐moderate load.